Global M&A expansion Recent acquisition activity by Dürr Group and historical growth through strategic acquisitions signal an expanding global footprint and expanded capabilities. This creates cross-sell opportunities across automotive, life sciences, and high-speed manufacturing segments, with potential for integrated automation solutions and platform-based offerings.

Medtech & life sciences Strong emphasis on life sciences and medtech automation, plus past acquisition of Kahle Automation to broaden exposure. Target customers in biopharma, diagnostics, and medical devices may require validated, compliant, high-speed assembly and test platforms, robotics, and vision inspection to meet regulatory standards.

Regulatory & quality edge ISO 45001 and ISO 9000 certifications plus validated, scalable automation for manufacturability and compliance present a compelling value proposition for highly regulated industries. Use this to upsell quality-focused customers seeking robust documentation, traceability, and process control.

Cross-border support One Source model with North American operations in Chicago, Atlanta, and Guadalajara combined with a global engineering network offers seamless regional and cross-border project execution. Highlight reliability for multinational manufacturers seeking consistent standards and support across sites.

High-value collaborations Integrated solutions combining robotics, vision inspection, smart material handling, and SCADA-enabled controls position BBS as a turnkey partner for high-mix, high-volume lines in life sciences, mobility, consumer products, and new energy. Focus on opportunities where speed to market and regulatory readiness are critical.